%0 Journal Article
%T Immunomodulating effects of the anti-viral agent Silibinin in liver transplant patients with HCV recurrence
%A Alfredo Di Leo
%A Angus W. Thomson
%A Antonino Castellaneta
%A Antonio Massaro
%A Francesca DĄŻErrico
%A Maria Rendina
%A Salvatore Fabio Rizzi
%A Sonia Carparelli
%J Archive of "Transplantation Research".
%D 2016
%R 10.1186/s13737-016-0030-7
%X Silibinin has been shown to have anti-HCV activity and immune-modulating properties by regulating dendritic cell (DC) function. DCs are antigen-presenting cells that, together with regulatory T cells (Treg), play a pivotal role in controlling alloimmune, as well as anti-HCV immune responses
%K Silibinin
%K Liver transplantation
%K HCV recurrence
%K Dendritic cells
%K Regulatory T cells
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4721199/